Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures

Kousei Hasegawa, Hiroyuki Tanaka, Yousuke Higuchi, Yumiko Hayashi, Katsuhiro Kobayashi, Hirokazu Tsukahara

Research output: Contribution to journalArticle

Abstract

Patients with 22q11.2 deletion syndrome have characteristic facial appearance, palate abnormalities, hypoparathyroidism, thymic hypoplasia, and congenital heart disease. The 22q11.2 region includes TBX1 and 30 other genes. Analysis of Tbx1 transgenic mice showed that TBX1 was associated with the 22q11.2 deletion syndrome. In humans, TBX1 mutations have been reported in 22q11.2 deletion-negative patients with velocardiofacial syndrome or DiGeorge syndrome. Genotype-phenotype correlations are not fully understood in these patients. We report the case of an infant with a novel heterozygous TBX1 mutation who experienced hypocalcemic seizures. This patient had no palate abnormalities, cardiac anomalies, or the typical facial appearance observed in 22q11.2 deletion syndrome. The presence of thymic hypoplasia prompted us to perform G-banding, fluorescent in situ hybridization, and subsequent TBX1 analysis. We emphasize the importance of diagnosing thymic hypoplasia in hypocalcemic infants without 22q11.2 deletion for detecting TBX1 mutations.

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalClinical Pediatric Endocrinology
Volume27
Issue number3
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

DiGeorge Syndrome
Seizures
Mutation
Palate
Hypoparathyroidism
Genetic Association Studies
Fluorescence In Situ Hybridization
Transgenic Mice
Heart Diseases
Genes

Keywords

  • Hypocalcemia
  • Hypoparathyroidism
  • Thymus gland

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures. / Hasegawa, Kousei; Tanaka, Hiroyuki; Higuchi, Yousuke; Hayashi, Yumiko; Kobayashi, Katsuhiro; Tsukahara, Hirokazu.

In: Clinical Pediatric Endocrinology, Vol. 27, No. 3, 01.01.2018, p. 159-164.

Research output: Contribution to journalArticle

@article{9786a777b031443c8af4608cd438e10a,
title = "Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures",
abstract = "Patients with 22q11.2 deletion syndrome have characteristic facial appearance, palate abnormalities, hypoparathyroidism, thymic hypoplasia, and congenital heart disease. The 22q11.2 region includes TBX1 and 30 other genes. Analysis of Tbx1 transgenic mice showed that TBX1 was associated with the 22q11.2 deletion syndrome. In humans, TBX1 mutations have been reported in 22q11.2 deletion-negative patients with velocardiofacial syndrome or DiGeorge syndrome. Genotype-phenotype correlations are not fully understood in these patients. We report the case of an infant with a novel heterozygous TBX1 mutation who experienced hypocalcemic seizures. This patient had no palate abnormalities, cardiac anomalies, or the typical facial appearance observed in 22q11.2 deletion syndrome. The presence of thymic hypoplasia prompted us to perform G-banding, fluorescent in situ hybridization, and subsequent TBX1 analysis. We emphasize the importance of diagnosing thymic hypoplasia in hypocalcemic infants without 22q11.2 deletion for detecting TBX1 mutations.",
keywords = "Hypocalcemia, Hypoparathyroidism, Thymus gland",
author = "Kousei Hasegawa and Hiroyuki Tanaka and Yousuke Higuchi and Yumiko Hayashi and Katsuhiro Kobayashi and Hirokazu Tsukahara",
year = "2018",
month = "1",
day = "1",
doi = "10.1297/cpe.27.159",
language = "English",
volume = "27",
pages = "159--164",
journal = "Clinical Pediatric Endocrinology",
issn = "0918-5739",
publisher = "Jeff Corporation Co. Ltd",
number = "3",

}

TY - JOUR

T1 - Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures

AU - Hasegawa, Kousei

AU - Tanaka, Hiroyuki

AU - Higuchi, Yousuke

AU - Hayashi, Yumiko

AU - Kobayashi, Katsuhiro

AU - Tsukahara, Hirokazu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Patients with 22q11.2 deletion syndrome have characteristic facial appearance, palate abnormalities, hypoparathyroidism, thymic hypoplasia, and congenital heart disease. The 22q11.2 region includes TBX1 and 30 other genes. Analysis of Tbx1 transgenic mice showed that TBX1 was associated with the 22q11.2 deletion syndrome. In humans, TBX1 mutations have been reported in 22q11.2 deletion-negative patients with velocardiofacial syndrome or DiGeorge syndrome. Genotype-phenotype correlations are not fully understood in these patients. We report the case of an infant with a novel heterozygous TBX1 mutation who experienced hypocalcemic seizures. This patient had no palate abnormalities, cardiac anomalies, or the typical facial appearance observed in 22q11.2 deletion syndrome. The presence of thymic hypoplasia prompted us to perform G-banding, fluorescent in situ hybridization, and subsequent TBX1 analysis. We emphasize the importance of diagnosing thymic hypoplasia in hypocalcemic infants without 22q11.2 deletion for detecting TBX1 mutations.

AB - Patients with 22q11.2 deletion syndrome have characteristic facial appearance, palate abnormalities, hypoparathyroidism, thymic hypoplasia, and congenital heart disease. The 22q11.2 region includes TBX1 and 30 other genes. Analysis of Tbx1 transgenic mice showed that TBX1 was associated with the 22q11.2 deletion syndrome. In humans, TBX1 mutations have been reported in 22q11.2 deletion-negative patients with velocardiofacial syndrome or DiGeorge syndrome. Genotype-phenotype correlations are not fully understood in these patients. We report the case of an infant with a novel heterozygous TBX1 mutation who experienced hypocalcemic seizures. This patient had no palate abnormalities, cardiac anomalies, or the typical facial appearance observed in 22q11.2 deletion syndrome. The presence of thymic hypoplasia prompted us to perform G-banding, fluorescent in situ hybridization, and subsequent TBX1 analysis. We emphasize the importance of diagnosing thymic hypoplasia in hypocalcemic infants without 22q11.2 deletion for detecting TBX1 mutations.

KW - Hypocalcemia

KW - Hypoparathyroidism

KW - Thymus gland

UR - http://www.scopus.com/inward/record.url?scp=85053157438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053157438&partnerID=8YFLogxK

U2 - 10.1297/cpe.27.159

DO - 10.1297/cpe.27.159

M3 - Article

AN - SCOPUS:85053157438

VL - 27

SP - 159

EP - 164

JO - Clinical Pediatric Endocrinology

JF - Clinical Pediatric Endocrinology

SN - 0918-5739

IS - 3

ER -